| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
21,110,000 |
| Market
Cap: |
5.48(M) |
| Last
Volume: |
4,769,812 |
Avg
Vol: |
4,756,624 |
| 52
Week Range: |
$0.2598 - $0.2598 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Plus Therapeutics is a clinical-stage pharmaceutical company focused on the development, manufacture and commercialization of treatments for patients battling cancer and other life-threatening diseases. The clinical stage drugs in Co.'s pipeline are: Rhenium NanoLiposomes, a radiotherapy for patients with recurrent glioblastoma; DocePLUS™, a chemotherapy for patients with tumors that has been evaluated in a completed U.S. single-center Phase 1 clinical trial; and DoxoPLUS™, a generic chemotherapy that has been evaluated in a completed, bioequivalence clinical trial in the U.S., Canada, and Ukraine versus Janssen's CAELYX® in patients with ovarian cancer.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
48,285 |
50,285 |
100,872 |
153,373 |
| Total Buy Value |
$98,501 |
$102,221 |
$185,764 |
$224,195 |
| Total People Bought |
6 |
6 |
6 |
6 |
| Total Buy Transactions |
6 |
8 |
17 |
22 |
| Total Shares Sold |
0 |
2,068 |
2,068 |
3,568 |
| Total Sell Value |
$0 |
$4,053 |
$4,053 |
$4,525 |
| Total People Sold |
0 |
1 |
1 |
2 |
| Total Sell Transactions |
0 |
1 |
1 |
2 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Dean Lloyd H |
Director |
– • – |
2011-05-20 |
4 |
B |
$5.27 |
$7,907 |
I/I |
1,500 |
1,500 |
2.1 |
- |
|
| Thompson Tommy G |
Director |
– • – |
2011-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
21,000 |
21,000 |
|
- |
|
| Shirahama Norio Seijiro |
President - Asia Pacific |
• – – |
2011-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
31,825 |
42,025 |
|
- |
|
| Saad Mark E |
Chief Financial Officer |
• – – |
2011-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
33,500 |
116,000 |
|
- |
|
| Hedrick Marc H |
President |
• • – |
2011-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
36,850 |
485,088 |
|
- |
|
| Calhoun Christopher J |
Chief Executive Officer |
• • – |
2011-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
50,250 |
133,375 |
|
- |
|
| Rickey David |
Director |
– • – |
2011-01-01 |
4 |
A |
$0.00 |
$0 |
I/I |
6,000 |
146,101 |
|
- |
|
| Henriksen Ronald D |
Director |
– • – |
2011-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
58,092 |
|
- |
|
| Holmes E Carmack |
Director |
– • – |
2011-01-01 |
4 |
A |
$0.00 |
$0 |
I/I |
6,000 |
24,401 |
|
- |
|
| Hawran Paul W |
Director |
– • – |
2011-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
66,610 |
|
- |
|
| Hawkins Richard J |
Director |
– • – |
2011-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
10,085 |
|
- |
|
| Calhoun Christopher J |
Chief Executive Officer |
• • – |
2010-12-22 |
4 |
AS |
$5.59 |
$273,909 |
D/D |
(48,125) |
83,125 |
|
- |
|
| Townsend John |
ControllerOfficer |
• – – |
2010-11-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
250 |
|
- |
|
| Dean Lloyd H |
Director |
– • – |
2010-11-01 |
4 |
A |
$4.70 |
$98,700 |
D/D |
21,000 |
21,000 |
|
- |
|
| Shirahama Norio Seijiro |
President - Asia Pacific |
• – – |
2010-06-04 |
4 |
B |
$4.57 |
$6,855 |
D/D |
1,500 |
10,200 |
2.74 |
- |
|
| Hawran Paul W |
Director |
– • – |
2010-05-24 |
4 |
B |
$4.65 |
$23,235 |
D/D |
5,000 |
60,610 |
2.39 |
- |
|
| Saad Mark E |
Chief Financial Officer |
• – – |
2010-05-21 |
4 |
B |
$4.28 |
$25,741 |
D/D |
6,000 |
82,500 |
2.74 |
- |
|
| Hawran Paul W |
Director |
– • – |
2010-05-19 |
4 |
B |
$4.83 |
$24,164 |
D/D |
5,000 |
55,610 |
2.39 |
- |
|
| Hawkins Richard J |
Director |
– • – |
2010-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
943 |
4,085 |
|
- |
|
| Rickey David |
Director |
– • – |
2010-02-09 |
4 |
A |
$0.00 |
$0 |
I/I |
1,195 |
140,101 |
|
- |
|
| Henriksen Ronald D |
Director |
– • – |
2010-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,568 |
52,092 |
|
- |
|
| Hawran Paul W |
Director |
– • – |
2010-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,294 |
50,610 |
|
- |
|
| Holmes E Carmack |
Director |
– • – |
2010-02-09 |
4 |
A |
$0.00 |
$0 |
I/I |
768 |
18,401 |
|
- |
|
| Rickey David |
Director |
– • – |
2010-01-21 |
4/A |
OE |
$3.12 |
$38,400 |
I/I |
10,000 |
134,800 |
|
- |
|
| Rickey David |
Director |
– • – |
2010-01-21 |
4 |
OE |
$3.12 |
$38,400 |
D/D |
10,000 |
14,106 |
|
- |
|
340 Records found
|
|
Page 8 of 14 |
|
|
